Melatonin Improves the Development Ability of Sheep Embryos by Reducing ROS During IVEP.

Reprod Domest Anim

State Key Laboratory of Sheep Genetic Improvement and Healthy Breeding, Institute of Animal Husbandry and Veterinary Sciences, Xinjiang Academy of Agricultural and Reclamation Sciences, Shihezi, China.

Published: May 2025


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Sheep in vitro embryo production (IVEP) is of great economic and scientific value, while reactive oxygen species (ROS) can negatively impact the quality and developmental potential of sheep embryos. Therefore, reducing ROS may enhance the efficacy of sheep IVEP. In this study, different concentrations of melatonin (10, 10, 10, 10 M) were supplemented during oocyte in vitro maturation (IVM) and embryo in vitro culture (IVC). The developmental ability of sheep oocytes and embryos, the survival rate of vitrified blastocysts, ROS level, ATP content, ATP synthase activity and related gene expression levels of sheep blastocysts were detected. The results showed that 10 M melatonin significantly improved the developmental ability of sheep oocytes and embryos, elevated the survival rate of blastocysts after vitrification, reduced the ROS level, increased the ATP content and ATP synthase activity and improved the expression levels of quality-related genes in sheep blastocysts. We speculated that melatonin may enhance the developmental competence of sheep oocytes and embryos by reducing the ROS level and promoting ATP synthesis. In addition, high concentrations of melatonin may have an adverse impact on the development of sheep embryos.

Download full-text PDF

Source
http://dx.doi.org/10.1111/rda.70061DOI Listing

Publication Analysis

Top Keywords

ability sheep
12
sheep embryos
12
embryos reducing
12
reducing ros
12
sheep oocytes
12
oocytes embryos
12
ros level
12
sheep
10
concentrations melatonin
8
developmental ability
8

Similar Publications

First isolation and identification of in sheep and goats: new insights and implications for veterinary medicine.

Front Microbiol

August 2025

Animal Health Laboratory, EU/WOAH and National Reference Laboratory for Brucellosis, Anses/Paris-Est University, Maisons-Alfort, France.

Many species from the genus are causative agents of the bacterial zoonosis brucellosis. Until recently, it was generally believed that these bacteria exhibit strict host specificity; however, recent findings suggest otherwise. is an atypical species, no threat to humans, with a broad host spectrum, primarily found in wildlife and rodents, and is the only species isolated from soil, aquatic environments, and frogs, suggesting its environmental persistence and adaptability to diverse ecological niches.

View Article and Find Full Text PDF

Hemolytic uremic syndrome caused by an invasive infection (SP-HUS) is a rare and severe disease that primarily affects children under two years of age. The pathophysiology of SP-HUS remains poorly understood, and treatment is largely supportive. Complement factor H (FH) is a key regulator of the alternative pathway of the complement system.

View Article and Find Full Text PDF

Background/objective: Plate failure, including bending, is a critical issue in orthopedic fracture fixation, with clinical failure rates of 3.5%-19%, burdening patients and healthcare systems. Preclinical ovine models have observed similar plate bending due to overloading.

View Article and Find Full Text PDF

is a facultative intracellular pathogen that has garnered attention as a potential cancer therapeutic due to its ability to induce robust cell-mediated immunity. To ensure safe clinical administration, deletion of certain genes, such as , has been used to attenuate -based vaccine strains while preserving immunogenicity. Here we explored the potential inclusion of a gene deletion to enhance the development of -based immunotherapy.

View Article and Find Full Text PDF

In the field of cardiovascular device development, new devices such as heart valves, stents or pressure probes for long term heart failure monitoring are subject to animal trials to evaluate their safety and efficacy. For such applications, swine and sheep are the animal models of choice owed to their similarities to humans with regards to heart size, weight and ventricular kinetics. However, clinical aspects regarding the choice of animal model revolve mainly around anatomical similarities as well as the ability to induce the desired pathology.

View Article and Find Full Text PDF